Dr. Rick Doblin (founder and president of the Multidisciplinary Association for Psychedelic Studies, and one of the most influential figures in psychedelic science) returns to Mayim Bialik's Breakdown for one of the most controversial and eye-opening conversations on psychedelics we've had yet.

From the shocking experiment where scientists gave MDMA to an octopus, to why ibogaine may be the most powerful AND dangerous psychedelic ever studied, this episode explores the future of psychedelic therapy, trauma healing, addiction recovery, policy reform, and human consciousness itself.

We break down Trump’s new executive order accelerating psychedelic research and what it could mean for the future legalization of psychedelic-assisted therapy in America. Dr. Doblin explains why veterans suffering from PTSD and disabilities have become central to bipartisan support for psychedelics, and why this issue is now reshaping politics on both sides of the aisle.

We also dive deep into ibogaine: its mysterious origins, its ability to help reset opioid addiction, its connection to ancestral memory and intergenerational trauma, why it carries serious risks, and why Dr. Doblin still believes its benefits may outweigh the dangers. He also shares his own profound ibogaine experience that helped him confront perfectionism and his fear of death.

Dr. Doblin discusses:

- How psychedelics help people integrate trauma

- Why psychedelics are generally considered non-addictive

- Difference between recreational vs therapeutic psychedelic use

- Why psychedelic treatment should be customized to each patient

- Importance of integration, peer support, and paying attention to dreams after treatment

- Measures of success in MDMA-assisted couples therapy

- Origins of the opioid epidemic

- "Psychedelic churches": How organizations are openly operating under the umbrella of religion

- Capitalism vs democratizing the benefits of psychedelic medicine

- How a better psychedelic therapy model could be built

- Why transparency is critical for science-backed drug policy reform

- When psychedelics may realistically enter the open market

- Dr. Doblin’s long-term vision for a psychedelic-informed public

As psychedelic research rapidly expands worldwide, this conversation explores the science, politics, risks, ethics, and revolutionary potential behind one of the fastest-growing movements in mental health and medicine!

DISCLAIMER: MBB is not providing medical or legal advice. Listeners should speak to their doctor before engaging in any course of psychedelic protocols. Psychedelics are still illegal in many places - MBB is not encouraging engaging in illegal substance use, but simply sharing the latest scientific insights from our guests.

Learn more about MAPS & their research: https://maps.org/
To learn more about the world’s largest psychedelic conference, Psychedelic Science, taking place in Denver, CO next year, visit: https://virtualtrip.maps.org/

Follow us on Substack for Exclusive Bonus Content: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bialikbreakdown.substack.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Part Two: 50 Million in Funding, 10,000 New Clinics, and the Mistake That Could Kill the Psychedelic Revolution | Dr. Rick Doblin

Mayim Bialik's Breakdown

Part Two: 50 Million in Funding, 10,000 New Clinics, and the Mistake That Could Kill the Psychedelic Revolution | Dr. Rick Doblin